| Product |
CAS |
Molecular formula |
More |
| 4-Ethyl-4-(4-fluorophenyl)bi(cyclohexane) |
114175-93-8 |
C20H29F |
More |
| 4-Ethyl-4-(3,4,5-trifluorophenyl)bi(cyclohexane) |
139215-80-8 |
C20H27F3 |
More |
| 4-Isopropylbenzeneboronic acid |
16150-51-5 |
C24H31N3 |
More |
| 3,5-Dimethoxybenzaldehyde |
311-34-4 |
|
More |
| 1H-1,4-diazepine, hexahydro-1-methyl-4-[5-(4,4,5,5-tetramethyl-1,3,2-d |
1015242-02-0 |
C9H14O3 |
More |
| 4-[2-[[5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-3-pyridinyl]oxy |
1010104-33-2 |
C5H6ClNO3 |
More |
| 2-[[5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-2-pyridinyl]amino] |
1005009-99-3 |
C9H13NO |
More |
| 4-Quinolinecarboxylic acid, 2-phenyl-3-(4,4,5,5-tetramethyl-1,3,2-diox |
1000007-26-0 |
C7H10F3NO2 |
More |
| 4-[[3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-2-pyridinyl]oxy]-b |
945599-51-9 |
C17H21BN2O3 |
More |
| 2-Pyridinecarboxamide, n-(6-methyl-2-pyridinyl)-5-(4,4,5,5-tetramethyl |
936091-08-6 |
C7H8F3NO2 |
More |
| 2-[2-(1-Pyrrolidinyl)ethoxy]-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan |
933986-99-3 |
C17H27BN2O3 |
More |
| 3-[[[5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-3-pyridinyl]methy |
919347-58-3 |
C15H22BN3O2 |
More |
| 3-[(2-Methyl-1-pyrrolidinyl)methyl]-5-(4,4,5,5-tetramethyl-1,3,2-dioxa |
919347-19-6 |
C17H27BN2O2 |
More |
| 4-[[5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-3-pyridinyl]methyl |
919347-16-3 |
C16H25BN2O3 |
More |
| Ethanamine, n,n-dimethyl-2-[[5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan |
892501-92-7 |
C15H25BN2O3 |
More |
| 2-(2,5-Dimethyl-1h-pyrrol-1-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaboro |
885226-07-3 |
|
More |
| 4-Methyl-2-(phenylmethoxy)-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2 |
882679-44-9 |
C19H24BNO3 |
More |
| 3-(2-Propen-1-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-pyri |
857934-96-4 |
|
More |
| 2-Pyridinamine, 3-(phenylmethoxy)-5-(4,4,5,5-tetramethyl-1,3,2-dioxabo |
756520-57-7 |
C8H4IN3 |
More |
| 3-Pyridinecarboxamide, n-(phenylmethyl)-5-(4,4,5,5-tetramethyl-1,3,2-d |
625470-38-4 |
C11H10IN3 |
More |
|
